Taken together, melanoma cells secreted a variety of proinflammatory factors, mainly cytokines, such as IL-1β and IL-8, and chemokines, such as CXCL10, CXCL11, and CCL20, during CIS, while during TIS, melanoma cells produced lower levels of SASP proteins. Here, IL1B is linked to in situ carcinoma.